Across TCGA pan-cancer cohorts, HNRNPA1P52 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated HNRNPA1P52 data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher HNRNPA1P52 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HNRNPA1P52 expression acts as an unfavorable survival marker, although some lineages such as GBM and PRAD show a favorable association.
KIRP, PCPG, and GBM are the cancer types where HNRNPA1P52 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.